Radiolabeled monoclonal antibodies for imaging and therapy
Our rough guess is there are 219,000 words in this book.
At a pace averaging 250 words per minute, this book will take 14 hours and 36 minutes to read. With a half hour per day, this will take 29 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Contributions
- Srivastava, Suresh C. - Contributor
- North Atlantic Treaty Organization. Scientific Affairs Division. - Contributor
Publication
1988 - Plenum Press, New York, New York (State)
Language
English
Word Count
219,000 words, Guess
Page Count
876 pages
Identifiers
- Open LibraryOL2042835M
- Internet Archiveradiolabeledmono0000nato
- ISBN-100306429829
- ISBN-139780306429828
- Goodreads4909024
Classifications
- DDC616.07/57
- LCCRC271.M65 N37 1986
Subjects
Topics
TumorsCancerTumeursImagingCongresTherapyImagerieNeoplasmsDiagnosisCongressesDiagnosticsRadiotherapyScintigraphieRadiotherapieDiagnostic useImmunotherapieTherapeutic useIsotope LabelingNeoplasms therapyDiagnostic imagingRadioimmunoimagingRadioimmunotherapyRadioimmunotherapieRadionuclide ImagingMonoclonal antibodiesAnticorps monoclonauxRadioisotope DiagnosisEmploi en therapeutiqueRadio immunoscintigraphieEmploi en symptomatologieImmunoglobulins monoclonalesIsotope Labeling -- congressesNeoplasms radionuclide imagingNeoplasms therapy -- congressesRadioisotope Diagnostic TechniquesAntibodies, Monoclonal -- congressesDiagnosis, Radioisotope -- congressesCancer -- Radioimmunotherapy -- CongressesCancer -- Radioimmunoimaging -- CongressesNeoplasms radionuclide imaging -- congressesMonoclonal antibodies -- Diagnostic use -- CongressesMonoclonal antibodies -- Therapeutic use -- Congresses
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!